CIK 0001819133 · Non-accelerated filer<br>Smaller reporting company
Tango Therapeutics, Inc.
Sign in to watch- Ticker
- TNGX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- Phone
- (857) 320-4900
- Business address
- 201 BROOKLINE AVENUE, SUITE 901, BOSTON, MA, 02215
- Former names
- BCTG Acquisition Corp.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $1,858,086
- in 6 filings, $1.9M under 10b5-1 plans
Net −$1,858,086. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 18 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-06-06 | MVA Investors, LLC See remarks | Sale | −63,000 | $7.24 | $456K | 420,524 |
| 2024-06-05 | Peters Malte Director | Grant or award | +6,250 | 11,250 | ||
| 2024-06-05 | Peters Malte Director | Grant or award · Stock Option (Right to Buy) | +37,500 | 37,500 | ||
| 2024-06-05 | Rothenberg Mace Director | Grant or award | +6,250 | 11,250 | ||
| 2024-06-05 | Rothenberg Mace Director | Grant or award · Stock Option (Right to Buy) | +37,500 | 37,500 | ||
| 2024-06-05 | Calhoun Lesley Ann Director | Grant or award 10b5-1 | +6,250 | 11,250 | ||
| 2024-06-05 | Calhoun Lesley Ann Director | Sale 10b5-1 | +5,000 | $7.21 | $36K | 6,250 |
| 2024-06-05 | Calhoun Lesley Ann Director | Grant or award · Stock Option (Right to Buy) 10b5-1 | +37,500 | 37,500 | ||
| 2024-06-05 | Ketchum John B Director | Grant or award | +4,687 | 14,687 | ||
| 2024-06-05 | Ketchum John B Director | Grant or award · Stock Option (Right to Buy) | +28,125 | 28,125 | ||
| 2024-06-05 | Borisy Alexis Director | Grant or award | +6,250 | 11,250 | ||
| 2024-06-05 | Borisy Alexis Director | Grant or award · Stock Option (Right to Buy) | +37,500 | 37,500 | ||
| 2024-05-03 | MVA Investors, LLC See remarks | Sale | −60,000 | $7.61 | $457K | 483,524 |
| 2024-05-02 | MVA Investors, LLC See remarks | Sale | −75,000 | $7.56 | $567K | 543,524 |
| 2024-05-01 | MVA Investors, LLC See remarks | Sale | −75,000 | $7.43 | $557K | 618,524 |
| 2024-02-20 | Third Rock Ventures IV, L.P. 10% owner | Sale | −162,500 | $12.00 | $1.9M | 19,201,475 |
| 2024-02-07 | Weber Barbara Chief Executive Officer | Sale | −4,457 | $12.62 | $56K | 1,535,167 |
| 2024-02-07 | Barry Douglas General Counsel | Sale | −1,354 | $12.62 | $17K | 43,981 |
| 2024-02-07 | Beckman Daniella Chief Financial Officer | Sale | −1,817 | $12.62 | $23K | 132,397 |
| 2024-02-07 | Crystal Adam See Remarks | Sale | −4,083 | $12.62 | $52K | 119,478 |
Page 8 of 11 · 211 trades